Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, offering promising enhancements throughout several health-related and industrial purposes. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, much more dependable choice for therapeutic use,